Production of infectious hepatitis C virus in tissue culture from a cloned viral genome T Wakita, T Pietschmann, T Kato, T Date, M Miyamoto, Z Zhao, K Murthy, ... Nature medicine 11 (7), 791-796, 2005 | 3455 | 2005 |
Hepatitis B: the virus and disease TJ Liang Hepatology 49 (S5), S13-S21, 2009 | 1425 | 2009 |
Pathogenesis, natural history, treatment, and prevention of hepatitis C TJ Liang, B Rehermann, LB Seeff, JH Hoofnagle Annals of internal medicine 132 (4), 296-305, 2000 | 1236 | 2000 |
Management of hepatitis B: summary of a clinical research workshop JH Hoofnagle, E Doo, TJ Liang, R Fleischer, ASF Lok Hepatology 45 (4), 1056-1075, 2007 | 1089 | 2007 |
Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA J Lucifora, Y Xia, F Reisinger, K Zhang, D Stadler, X Cheng, MF Sprinzl, ... Science 343 (6176), 1221-1228, 2014 | 1077 | 2014 |
A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis K Promrat, G Lutchman, GI Uwaifo, RJ Freedman, A Soza, T Heller, E Doo, ... Hepatology 39 (1), 188-196, 2004 | 1016 | 2004 |
Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease AS Lok, LB Seeff, TR Morgan, AM Di Bisceglie, RK Sterling, TM Curto, ... Gastroenterology 136 (1), 138-148, 2009 | 831 | 2009 |
Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection H Wedemeyer, XS He, M Nascimbeni, AR Davis, HB Greenberg, ... The Journal of Immunology 169 (6), 3447-3458, 2002 | 830 | 2002 |
Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy R Loomba, A Rowley, R Wesley, TJ Liang, JH Hoofnagle, F Pucino, ... Annals of internal medicine 148 (7), 519-528, 2008 | 659 | 2008 |
Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment ML Shiffman, AM Di Bisceglie, KL Lindsay, C Morishima, EC Wright, ... Gastroenterology 126 (4), 1015-1023, 2004 | 652 | 2004 |
Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma JC Chambers, W Zhang, J Sehmi, X Li, MN Wass, P Van der Harst, ... Nature genetics 43 (11), 1131-1138, 2011 | 630 | 2011 |
Hepatitis B reactivation associated with immune suppressive and biological modifier therapies: current concepts, management strategies, and future directions R Loomba, TJ Liang Gastroenterology 152 (6), 1297-1309, 2017 | 617 | 2017 |
Abnormal structure and expression of p53 gene in human hepatocellular carcinoma. B Bressac, KM Galvin, TJ Liang, KJ Isselbacher, JR Wands, M Ozturk Proceedings of the National Academy of Sciences 87 (5), 1973-1977, 1990 | 598 | 1990 |
Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection D Milich, TJ Liang Hepatology 38 (5), 1075-1086, 2003 | 596 | 2003 |
A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis TJ Liang, K Hasegawa, N Rimon, JR Wands, E Ben-Porath New England Journal of Medicine 324 (24), 1705-1709, 1991 | 587 | 1991 |
Current and future therapies for hepatitis C virus infection TJ Liang, MG Ghany New England Journal of Medicine 368 (20), 1907-1917, 2013 | 578 | 2013 |
Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon AM Di Bisceglie, ML Shiffman, GT Everson, KL Lindsay, JE Everhart, ... New England Journal of Medicine 359 (23), 2429-2441, 2008 | 562 | 2008 |
The association of genetic variability in patatin‐like phospholipase domain‐containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease Y Rotman, C Koh, JM Zmuda, DE Kleiner, TJ Liang, NASH CRN Hepatology 52 (3), 894-903, 2010 | 551 | 2010 |
Progression of fibrosis in chronic hepatitis C MG Ghany, DE Kleiner, H Alter, E Doo, F Khokar, K Promrat, D Herion, ... Gastroenterology 124 (1), 97-104, 2003 | 535 | 2003 |
Hepatitis C virus structural proteins assemble into viruslike particles in insect cells TF Baumert, S Ito, DT Wong, TJ Liang Journal of virology 72 (5), 3827-3836, 1998 | 525 | 1998 |